n/a
Abstract Title:

Nuciferine Inhibits Skin Cutaneous Melanoma Cell Growth by Suppressing TLR4/NF-κB Signaling.

Abstract Source:

Anticancer Agents Med Chem. 2020 Aug 10. Epub 2020 Aug 10. PMID: 32781974

Abstract Author(s):

Jingxing Xu, Anxin Ying, Tongxin Shi

Article Affiliation:

Jingxing Xu

Abstract:

BACKGROUND: Melanoma causes more than 80% of deaths from all dermatologic cancers. Hence, screening and identifying effective compounds to inhibit the growth of melanoma have crucial importance in basic and clinical treatment.

METHODS: High throughput screening was performed to screen and identify compounds which have anti-melanoma ability. Melanoma cell and mouse allograft models was used to examine the anti-tumor effects of Nuciferine (NCFR). Western blot, qPCR, and lentivirus overexpression were applied to detect the activation of TLR4/NF-κB signaling pathway.

RESULTS: NCFR administration significantly suppressed melanoma cell growth and tumor size by inhibiting the phosphorylation of p65. NCFR treatment also could suppress TNF-α-induced activation of NF-κB signaling. The anti-tumor effect of NCFR might be mediated by targeting Toll-like receptors 4.

CONCLUSION: NCFR inhibits melanoma cell growth and suppresses tumor size, which provides a potential therapeutic strategies of melanoma treatment.

Print Options


Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2020 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.